Cancer cells corrupt normal epithelial cells through miR-let-7c-rich small extracellular vesicle-mediated downregulation of p53/PTEN

Abstract

Tumor volume increases continuously in the advanced stage, and aside from the self-renewal of tumor cells, whether the oncogenic transformation of surrounding normal cells is involved in this process is currently unclear. Here, we show that oral squamous cell carcinoma (OSCC)-derived small extracellular vesicles (sEVs) promote the proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT) of normal epithelial cells but delay their apoptosis. In addition, nuclear-cytoplasmic invaginations and multiple nucleoli are observed in sEV-treated normal cells, both of which are typical characteristics of premalignant lesions of OSCC. Mechanistically, miR-let-7c in OSCC-derived sEVs is transferred to normal epithelial cells, leading to the transcriptional inhibition of p53 and inactivation of the p53/PTEN pathway. In summary, we demonstrate that OSCC-derived sEVs promote the precancerous transformation of normal epithelial cells, in which the miR-let-7c/p53/PTEN pathway plays an important role. Our findings reveal that cancer cells can corrupt normal epithelial cells through sEVs, which provides new insight into the progression of OSCC.

References

[1] Sung H, . Global Cancer Statistics 2020: GLOBOCAN Estimates oF Incidence And Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J. Clin., 2021, 71: 209-249.

[2] Johnson DE, . Head and neck squamous cell carcinoma. Nat. Rev. Dis. Prim., 2020, 6: 92.

[3] Tsou HH, . Cigarette smoke containing acrolein upregulates egfr signaling contributing to oral tumorigenesis in vitro and in vivo. Cancers (Basel)., 2021, 13: 3544.

[4] Vineis P, Wild CP. Global cancer patterns: causes and prevention. Lancet, 2014, 383: 549-557.

[5] Chadwick JW, Macdonald R, Ali AA, Glogauer M, Magalhaes MA. TNFα signaling is increased in progressing oral potentially malignant disorders and regulates malignant transformation in an oral carcinogenesis model. Front. Oncol., 2021, 11: 741013.

[6] Lorini L, . Overview of oral potentially malignant disorders: From risk factors to specific therapies. Cancers (Basel)., 2021, 13: 1-16.

[7] Elmusrati A, Wang J, Wang CY. Tumor microenvironment and immune evasion in head and neck squamous cell carcinoma. Int. J. Oral. Sci., 2021, 13: 24.

[8] Custódio M, Biddle A, Tavassoli M. Portrait of a CAF: the story of cancer-associated fibroblasts in head and neck cancer. Oral. Oncol., 2020, 110: 104972.

[9] Huang T, . Targeting cancer-associated fibroblast-secreted WNT2 restores dendritic cell-mediated antitumour immunity. Gut, 2021, 71: 333-344.

[10] Patil PU, D’Ambrosio J, Inge LJ, Mason RW, Rajasekaran AK. Carcinoma cells induce lumen filling and EMT in epithelial cells through soluble E-cadherin-mediated activation of EGFR. J. Cell Sci., 2015, 128: 4366-4379.

[11] Huang SH, O’Sullivan B. Overview of the 8th edition TNM classification for head and neck cancer. Curr. Treat. Options Oncol., 2017, 18: 40.

[12] Ludwig N, . Novel TGFb inhibitors ameliorate oral squamous cell carcinoma progression and improve the antitumor immune response of anti-PD-L1 immunotherapy. Mol. Cancer Ther., 2021, 20: 1102-1111.

[13] Xu R, . Extracellular vesicles in cancer—implications for future improvements in cancer care. Nat. Rev. Clin. Oncol., 2018, 15: 617-638.

[14] Daßler-Plenker J, Küttner V, Egeblad M. Communication in tiny packages: exosomes as means of tumor-stroma communication. Biochim. Biophys. Acta - Rev. Cancer, 2020, 1873: 188340.

[15] Czystowska-Kuzmicz M, . Small extracellular vesicles containing arginase-1 suppress T-cell responses and promote tumor growth in ovarian carcinoma. Nat. Commun., 2019, 10

[16] Zhou X, . Melanoma cell-secreted exosomal miR-155- 5p induce proangiogenic switch of cancer-associated fibroblasts via SOCS1 / JAK2 / STAT3 signaling pathway. J. Exp. Clin. Cancer Res., 2018, 37: 242.

[17] Jiang E, . Tumoral microvesicle–activated glycometabolic reprogramming in fibroblasts promotes the progression of oral squamous cell carcinoma. FASEB J., 2019, 33: 5690-5703.

[18] Zomer A, . In vivo imaging reveals extracellular vesicle-mediated phenocopying of metastatic behavior. Cell, 2015, 161: 1046-1057.

[19] Théry C, . Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J. Extracell. Vesicles., 2018, 7: 1535750.

[20] Ou Y, . Helicobacter pylori CagA promotes the malignant transformation of gastric mucosal epithelial cells through the dysregulation of the miR-155/KLF4 signaling pathway. Mol. Carcinog., 2019, 58: 1427-1437.

[21] Repullés J, . Radiation-induced malignant transformation of preneoplastic and normal breast primary epithelial cells. Mol. Cancer Res., 2019, 17: 937-948.

[22] Lambert AW, Weinberg RA. Linking EMT programmes to normal and neoplastic epithelial stem cells. Nat. Rev. Cancer, 2021, 21: 325-338.

[23] Walen KH. Cell cycle stress in normal human cells: a route to “first cells” (with/without fitness gain) and cancer-like cell-shape changes. Semin. Cancer Biol., 2021, 81: 73-82.

[24] Shibue T, Weinberg RA. EMT, CSCs, and drug resistance: the mechanistic link and clinical implications. Nat. Rev. Clin. Oncol., 2017, 14: 611-629.

[25] Dongre A, Weinberg RA. New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer. Nat. Rev. Mol. Cell Biol., 2019, 20: 69-84.

[26] Nieto MA, Huang RY, Jackson RA, Thiery JP. EMT: 2016. Cell, 2016, 166: 21-45.

[27] Olinici D, . The ultrastructural features of the premalignant oral lesions. Rom. J. Morphol. Embryol., 2018, 59: 243-248.

[28] Hu J, . Targeting mutant p53 for cancer therapy: direct and indirect strategies. J. Hematol. Oncol., 2021, 14: 157.

[29] Chen L, Liu S, Tao Y. Regulating tumor suppressor genes: post-translational modifications. Signal Transduct. Target Ther., 2020, 5: 90.

[30] Chai AWY, Lim KP, Cheong SC. Translational genomics and recent advances in oral squamous cell carcinoma. Semin. Cancer Biol., 2020, 61: 71-83.

[31] Quail DF, Joyce JA. The microenvironmental landscape of brain tumors. Cancer Cell., 2017, 31: 326-341.

[32] Duan Q, Zhang H, Zheng J, Zhang L. Turning cold into hot: firing up the tumor microenvironment. Trends Cancer, 2020, 6: 605-618.

[33] Reese M, Dhayat SA. Small extracellular vesicle non-coding RNAs in pancreatic cancer: molecular mechanisms and clinical implications. J. Hematol. Oncol., 2021, 14: 141.

[34] Wu H, . The role and application of small extracellular vesicles in gastric cancer. Mol. Cancer, 2021, 20

[35] Li S-R, . Tissue-derived extracellular vesicles in cancers and non-cancer diseases: present and future. J. Extracell. Vesicles, 2021, 10: e12175.

[36] Sawada K, . Immunohistochemical staining patterns of p53 predict the mutational status of TP53 in oral epithelial dysplasia. Mod. Pathol., 2021, 35: 177-185.

[37] Singh B, . p53 regulates cell survival by inhibiting PIK3CA in squamous cell carcinomas. Genes Dev., 2002, 16: 984-993.

[38] Hung PS, . miR-31 is upregulated in oral premalignant epithelium and contributes to the immortalization of normal oral keratinocytes. Carcinogenesis, 2014, 35: 1162-1171.

[39] Xie Y, . Let-7c inhibits cholangiocarcinoma growth but promotes tumor cell invasion and growth at extrahepatic sites article. Cell Death Dis., 2018, 9

[40] Jiang T, Wang X, Wu W, Zhang F, Wu S. Let-7c miRNA Inhibits the proliferation and migration of heat-denatured dermal fibroblasts through down-regulating HSP70. Mol. Cells, 2016, 39: 345-351.

[41] Spolverini A, Fuchs G, Bublik DR, Oren M. Let-7b and let-7c microRNAs promote histone H2B ubiquitylation and inhibit cell migration by targeting multiple components of the H2B deubiquitylation machinery. Oncogene, 2017, 36: 5819-5828.

[42] Hilly O, . Distinctive pattern of let-7 family microRNAs in aggressive carcinoma of the oral tongue in young patients. Oncol. Lett., 2016, 12: 1729-1736.

[43] Chen Y, Liang W, Liu K, Shang Z. FOXD1 promotes EMT and cell stemness of oral squamous cell carcinoma by transcriptional activation of SNAI2. Cell Biosci., 2021, 11: 154.

Funding

National Natural Science Foundation of China (National Science Foundation of China)(81972547, 81972547, 81972547, 81972547, 81972547, 81972547, 81972547, 81972547)